Could a simple breathing machine replace Blood-Letting for High-Altitude disease?
NCT ID NCT07600086
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a non-invasive ventilator (a mask that helps you breathe at night) can lower hemoglobin levels in people with high-altitude polycythemia, a condition where the blood becomes too thick due to low oxygen. About 70 adults living at high altitudes will either receive standard care or standard care plus nightly ventilator use. The main goal is to see if hemoglobin drops after 3 and 6 months, which would mean less strain on the heart and blood vessels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- non-invasive ventilator (CPAP or BiPAP)
- What this could lead to
- If it works, this could offer a new, drug-free way to manage high-altitude polycythemia and reduce the risk of complications like blood clots.
- What could go wrong
- This is a small, early-stage study with only 70 participants, so results may not apply to everyone. The treatment requires wearing a mask during sleep, which some may find uncomfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAPC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
People's Hospital of Xizang Autonomous Region；Lhasa, Xizang Autonomous Region, China, 850000
Xizang, China
-
Xizang Autonomous Region People's Hospital
Xizang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.